Publications

Potent inhibitors of malarial P. Falciparum protein kinase G: Improving the cell activity of a series of imidazopyridines.

Large, JM; Birchall, K; Bouloc, NS; Merritt, AT; Smiljanic-Hurley, E; Tsagris, DJ; Wheldon, MC; Ansell, KH; Coombs, PJ; Kettleborough, CA; Whalley, D; STEWART, LB; Bowyer, PW; BAKER, DA; Osborne, SA;

2018

Bioorganic & medicinal chemistry letters, (2018).29 3 10.1016/j.bmcl.2018.11.039.

Safety of single low-dose primaquine in glucose-6-phosphate dehydrogenase deficient falciparum-infected African males: Two open-label, randomized, safety trials.

Bastiaens, GJ H; Tiono, AB; Okebe, J; Pett, HE; Coulibaly, SA; GONÇALVES, BP; Affara, M; Ouédraogo, A; Bougouma, EC; Sanou, GS; Nébié, I; BRADLEY, J; Lanke, KH W; Niemi, M; Sirima, SB; D'ALESSANDRO, U; BOUSEMA, T; DRAKELEY, C;

2018

PloS one, (2018).13 1 10.1371/journal.pone.0190272.

Assessment of community-level effects of intermittent preventive treatment for malaria in schoolchildren in Jinja, Uganda (START-IPT trial): a cluster-randomised trial.

STAEDKE, SG; Maiteki-Sebuguzi, C; REHMAN, AM; KIGOZI, SP; Gonahasa, S; Okiring, J; Lindsay, SW; Kamya, MR; CHANDLER, CI R; Dorsey, G; DRAKELEY, C;

2018

The Lancet Global health, (2018).6 6 10.1016/S2214-109X(18)30126-8.

Effect of environmental variables and kdr resistance genotype on survival probability and infection rates in Anopheles gambiae (s.s.).

KRISTAN, M; Abeku, TA; LINES, J;

2018

Parasites & vectors, (2018).11 1 10.1186/s13071-018-3150-8.

Malaria-Update on Antimalarial Resistance and Treatment Approaches.

YEUNG, S;

2018

The Pediatric infectious disease journal, (2018).37 4 10.1097/INF.0000000000001887.

Supporting capacity for research on malaria in Africa.

GREENWOOD, B; Gaye, O; Kamya, MR; Kibiki, G; Mwapasa, V; Phiri, KS; TAGBOR, H; Terlouw, D; Bates, I; Craig, A; Magnussen, P; Theander, TG; Bhasin, A; MCCULLOUGH, H; SCHELLENBERG, D;

2018

BMJ global health, (2018).3 2 10.1136/bmjgh-2018-000723.

Global genetic diversity of var2csa in Plasmodium falciparum with implications for malaria in pregnancy and vaccine development.

Benavente, ED; Oresegun, DR; De Sessions, PF; WALKER, EM; ROPER, C; Dombrowski, JG; De Souza, RM; Marinho, CR F; SUTHERLAND, CJ; HIBBERD, ML; Mohareb, F; BAKER, DA; CLARK, TG; CAMPINO, S;

2018

Scientific reports, (2018).8 1 10.1038/s41598-018-33767-3.

New Syndromes Identified by Neuroimaging during Cerebral Malaria.

Hoffmann, A; WASSMER, SC;

2018

The American journal of tropical medicine and hygiene, (2018).98 2 10.4269/ajtmh.17-0926.

Publisher Correction: Unravelling the immune signature of Plasmodium falciparum transmission-reducing immunity.

STONE, WJ R; Campo, JJ; Ouédraogo, AL; Meerstein-Kessel, L; Morlais, I; Da, D; Cohuet, A; Nsango, S; SUTHERLAND, CJ; Van de Vegte-Bolmer, M; Siebelink-Stoter, R; Van Gemert, G-J; Graumans, W; Lanke, K; Shandling, AD; Pablo, JV; Teng, AA; Jones, S; De Jong, RM; Fabra-García, A; BRADLEY, J; Roeffen, W; Lasonder, E; Gremo, G; Schwarzer, E; ... Jore, MM.

2018

Nature communications, (2018).9 1 10.1038/s41467-018-03769-w.

Epistasis studies reveal redundancy among calcium-dependent protein kinases in motility and invasion of malaria parasites.

Fang, H; Gomes, AR; Klages, N; Pino, P; Maco, B; WALKER, EM; Zenonos, ZA; Angrisano, F; Baum, J; Doerig, C; BAKER, DA; Billker, O; Brochet, M;

2018

Nature communications, (2018).9 1 10.1038/s41467-018-06733-w.